CN105145545A - 用于常温条件下长期保存和运输组织样本的核酸保护液 - Google Patents
用于常温条件下长期保存和运输组织样本的核酸保护液 Download PDFInfo
- Publication number
- CN105145545A CN105145545A CN201510445725.6A CN201510445725A CN105145545A CN 105145545 A CN105145545 A CN 105145545A CN 201510445725 A CN201510445725 A CN 201510445725A CN 105145545 A CN105145545 A CN 105145545A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- nucleic acid
- tissue
- protection liquid
- nuclease protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 41
- 108020004707 nucleic acids Proteins 0.000 title abstract description 17
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 17
- 102000039446 nucleic acids Human genes 0.000 title abstract description 17
- 230000007774 longterm Effects 0.000 title abstract description 3
- 230000001681 protective effect Effects 0.000 title abstract 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims abstract description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 16
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims abstract description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 13
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 8
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims abstract description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 8
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 102000004877 Insulin Human genes 0.000 claims abstract description 8
- 108090001061 Insulin Proteins 0.000 claims abstract description 8
- 229930182555 Penicillin Natural products 0.000 claims abstract description 8
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- PZMVOUYYNKPMSI-UHFFFAOYSA-N adrenalone Chemical compound CNCC(=O)C1=CC=C(O)C(O)=C1 PZMVOUYYNKPMSI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960002892 adrenalone Drugs 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 8
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 8
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims abstract description 8
- 229960003942 amphotericin b Drugs 0.000 claims abstract description 8
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 8
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 8
- 229960003178 choline chloride Drugs 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000367 inositol Drugs 0.000 claims abstract description 8
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 8
- 229940125396 insulin Drugs 0.000 claims abstract description 8
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 8
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940049954 penicillin Drugs 0.000 claims abstract description 8
- 229960003387 progesterone Drugs 0.000 claims abstract description 8
- 239000000186 progesterone Substances 0.000 claims abstract description 8
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960005322 streptomycin Drugs 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960000304 folic acid Drugs 0.000 claims abstract description 7
- 235000019152 folic acid Nutrition 0.000 claims abstract description 7
- 239000011724 folic acid Substances 0.000 claims abstract description 7
- 101710163270 Nuclease Proteins 0.000 claims description 31
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 14
- 206010028980 Neoplasm Diseases 0.000 claims description 12
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 claims description 7
- 108010016626 Dipeptides Proteins 0.000 claims description 7
- 239000007995 HEPES buffer Substances 0.000 claims description 7
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 7
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 7
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 7
- 235000020778 linoleic acid Nutrition 0.000 claims description 7
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 7
- 229960002898 threonine Drugs 0.000 claims description 7
- 239000004474 valine Substances 0.000 claims description 7
- 235000019160 vitamin B3 Nutrition 0.000 claims description 7
- 239000011708 vitamin B3 Substances 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 210000002569 neuron Anatomy 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 abstract 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 abstract 1
- 229930003756 Vitamin B7 Natural products 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 108010044940 alanylglutamine Proteins 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 235000011912 vitamin B7 Nutrition 0.000 abstract 1
- 239000011735 vitamin B7 Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 29
- 239000000284 extract Substances 0.000 description 16
- 238000005251 capillar electrophoresis Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 206010003571 Astrocytoma Diseases 0.000 description 5
- 208000000172 Medulloblastoma Diseases 0.000 description 5
- 210000001130 astrocyte Anatomy 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 210000004498 neuroglial cell Anatomy 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 229940054666 biotin 0.15 mg Drugs 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940019142 folic acid 5 mg Drugs 0.000 description 1
- 208000029824 high grade glioma Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 201000011614 malignant glioma Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510445725.6A CN105145545B (zh) | 2015-07-27 | 2015-07-27 | 用于常温条件下长期保存和运输组织样本的核酸保护液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510445725.6A CN105145545B (zh) | 2015-07-27 | 2015-07-27 | 用于常温条件下长期保存和运输组织样本的核酸保护液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105145545A true CN105145545A (zh) | 2015-12-16 |
CN105145545B CN105145545B (zh) | 2017-11-03 |
Family
ID=54786949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510445725.6A Active CN105145545B (zh) | 2015-07-27 | 2015-07-27 | 用于常温条件下长期保存和运输组织样本的核酸保护液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105145545B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106689115A (zh) * | 2016-11-30 | 2017-05-24 | 广州赛莱拉干细胞科技股份有限公司 | 一种脐带保存液及其应用 |
CN108471736A (zh) * | 2016-01-14 | 2018-08-31 | 德普伊新特斯产品公司 | 用于冷冻保存hutc的组合物和方法 |
CN109169638A (zh) * | 2018-11-12 | 2019-01-11 | 苏州瑞徕生物科技有限公司 | 一种细胞保存液及其用途 |
CN113462741A (zh) * | 2021-05-16 | 2021-10-01 | 苏州标点生物科技有限公司 | 一种常温下长期保存核酸的试剂及方法 |
CN113736916A (zh) * | 2021-08-25 | 2021-12-03 | 苏州锐讯生物科技有限公司 | 用于快速检测新型冠状病毒的荧光定量pcr试剂盒及其应用 |
WO2023240500A1 (zh) * | 2022-06-15 | 2023-12-21 | 深圳华大智造科技股份有限公司 | 保存dNTP的方法 |
CN117512069A (zh) * | 2023-12-07 | 2024-02-06 | 圣湘生物科技股份有限公司 | 一种核酸检测方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1109110A1 (ru) * | 1981-06-30 | 1984-08-23 | Институт Физиологии Им.А.И.Караева | Состав дл консервировани печени |
CN1560236A (zh) * | 2004-03-11 | 2005-01-05 | 中国人民解放军第二军医大学 | 一种细胞培养试剂及其用途 |
CN101386837A (zh) * | 2007-09-12 | 2009-03-18 | 北京天昕和生物科技有限公司 | 一种动物细胞培养方法 |
US20090263780A1 (en) * | 2008-04-17 | 2009-10-22 | Yanming Wang | Organ preservation fluid |
CN101999343A (zh) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | 一种细胞保存液、其制备方法及用途 |
CN104140949A (zh) * | 2014-08-08 | 2014-11-12 | 山东威高新生医疗器械有限公司 | 囊胚培养液及其制备方法 |
CN104542578A (zh) * | 2015-02-05 | 2015-04-29 | 广州赛莱拉干细胞科技股份有限公司 | 一种细胞保存液及其制备方法、应用 |
CN104673717A (zh) * | 2015-02-12 | 2015-06-03 | 中国医科大学 | 一种生物组织rna保护试剂及其制备方法和应用 |
-
2015
- 2015-07-27 CN CN201510445725.6A patent/CN105145545B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1109110A1 (ru) * | 1981-06-30 | 1984-08-23 | Институт Физиологии Им.А.И.Караева | Состав дл консервировани печени |
CN1560236A (zh) * | 2004-03-11 | 2005-01-05 | 中国人民解放军第二军医大学 | 一种细胞培养试剂及其用途 |
CN101386837A (zh) * | 2007-09-12 | 2009-03-18 | 北京天昕和生物科技有限公司 | 一种动物细胞培养方法 |
US20090263780A1 (en) * | 2008-04-17 | 2009-10-22 | Yanming Wang | Organ preservation fluid |
CN101999343A (zh) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | 一种细胞保存液、其制备方法及用途 |
CN104140949A (zh) * | 2014-08-08 | 2014-11-12 | 山东威高新生医疗器械有限公司 | 囊胚培养液及其制备方法 |
CN104542578A (zh) * | 2015-02-05 | 2015-04-29 | 广州赛莱拉干细胞科技股份有限公司 | 一种细胞保存液及其制备方法、应用 |
CN104673717A (zh) * | 2015-02-12 | 2015-06-03 | 中国医科大学 | 一种生物组织rna保护试剂及其制备方法和应用 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108471736A (zh) * | 2016-01-14 | 2018-08-31 | 德普伊新特斯产品公司 | 用于冷冻保存hutc的组合物和方法 |
CN106689115A (zh) * | 2016-11-30 | 2017-05-24 | 广州赛莱拉干细胞科技股份有限公司 | 一种脐带保存液及其应用 |
CN109169638A (zh) * | 2018-11-12 | 2019-01-11 | 苏州瑞徕生物科技有限公司 | 一种细胞保存液及其用途 |
CN113462741A (zh) * | 2021-05-16 | 2021-10-01 | 苏州标点生物科技有限公司 | 一种常温下长期保存核酸的试剂及方法 |
CN113736916A (zh) * | 2021-08-25 | 2021-12-03 | 苏州锐讯生物科技有限公司 | 用于快速检测新型冠状病毒的荧光定量pcr试剂盒及其应用 |
WO2023240500A1 (zh) * | 2022-06-15 | 2023-12-21 | 深圳华大智造科技股份有限公司 | 保存dNTP的方法 |
CN117512069A (zh) * | 2023-12-07 | 2024-02-06 | 圣湘生物科技股份有限公司 | 一种核酸检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105145545B (zh) | 2017-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105145545A (zh) | 用于常温条件下长期保存和运输组织样本的核酸保护液 | |
Shulman et al. | Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin | |
THEVELEIN et al. | Regulation of the cAMP level in the yeast Saccharomyces cerevisiae: intracellular pH and the effect of membrane depolarizing compounds | |
CN101762710B (zh) | 一种多项液体质控物及其制备方法 | |
US5348852A (en) | Diagnostic and therapeutic compositions | |
US10625242B2 (en) | Substrates and methods for collection, stabilization and elution of biomolecules | |
JPH10503380A (ja) | 精製した生物学的及び化学的試薬の連続的供給 | |
JP2007275065A (ja) | 安定化酵素組成物 | |
EP3134441B1 (en) | Substrates and methods for collection, stabilization and elution of biomolecules | |
Knorr et al. | An enzymatic method fob yeast autolysis | |
CN108949748B (zh) | 一种痰液液化及核酸保护试剂 | |
Guerrieri et al. | A novel amperometric biosensor based on a co-crosslinked l-lysine-α-oxidase/overoxidized polypyrrole bilayer for the highly selective determination of l-lysine | |
Bhati et al. | An effective method for saliva stabilization and magnetic nanoparticles based DNA extraction for genomic applications | |
Tok et al. | Glutamine accumulation and up-regulation of glutamine synthetase activity in the swamp eel, Monopterus albus (Zuiew), exposed to brackish water | |
CN116508744B (zh) | 用于新冠病毒抗原检测的样本保存液及其制备方法 | |
Weimberg et al. | Kinetics of toluene-induced leakage of low molecular weight solutes from excised sorghum tissues | |
Jung et al. | Ammonia transport is independent of PNH3 gradients across the gastrointestinal epithelia of the rainbow trout: A role for the stomach | |
CN104910254B (zh) | 二肽Pro-Asp在促进动物肝细胞分泌IGF-1方面的应用 | |
Dijkhuizen et al. | Uptake of methylamine via an inducible, energy-dependent transport system in the facultative methylotroph Arthrobacter P1 | |
DE19503685C2 (de) | Verfahren zur Herstellung komplexer multienzymatischer lagerstabiler Reaktionsgemische und deren Verwendung | |
JPH0391491A (ja) | 血清アルブミンの製造方法 | |
JP2002101869A (ja) | 脱水ストレス保護剤 | |
Bajpai et al. | Protective effect of heat-treated cucumber (Cucumis sativus L.) juice on alcohol detoxification in experimental rats. | |
CN110997933A (zh) | 用于稳定无细胞核酸和细胞的方法和组合物 | |
CN111662371B (zh) | 细胞角蛋白19片段抗原及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160601 Address after: 102206 Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 11 Building 2 layer Applicant after: GENETRON HEALTH (BEIJING) Co.,Ltd. Address before: 100176 Beijing City, Daxing District branch of Beijing economic and Technological Development Zone, fourteen Street No. 99 building 33 Room 101 building D Applicant before: BEIJING GENETRON HEALTH BIOTECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170606 Address after: 102206 Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 11 Building 2 layer Applicant after: GENETRON HEALTH (BEIJING) Co.,Ltd. Applicant after: GENETRON HEALTH(CHONGQING) LABORATORY Co.,Ltd. Address before: 102206 Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 11 Building 2 layer Applicant before: GENETRON HEALTH (BEIJING) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220106 Address after: 214000, floor 5, No. 1719-15, Huishan Avenue, Huishan Economic Development Zone, Wuxi City, Jiangsu Province Patentee after: Wuxi fanshengzi Biotechnology Co.,Ltd. Patentee after: GENETRON HEALTH (BEIJING) Co.,Ltd. Patentee after: GENETRON HEALTH(CHONGQING) LABORATORY Co.,Ltd. Address before: 102206 2nd floor, building 11, area 1, No.8, shengshengyuan Road, Zhongguancun Life Science Park, Huilongguan town, Changping District, Beijing Patentee before: GENETRON HEALTH (BEIJING) Co.,Ltd. Patentee before: GENETRON HEALTH(CHONGQING) LABORATORY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221110 Address after: 214174 Floor 5, No. 8-6, Huide Road, Huishan Economic Development Zone, Wuxi, Jiangsu Province Patentee after: Wuxi fanshengzi Biotechnology Co.,Ltd. Patentee after: GENETRON HEALTH (BEIJING) Co.,Ltd. Address before: 214000, floor 5, No. 1719-15, Huishan Avenue, Huishan Economic Development Zone, Wuxi City, Jiangsu Province Patentee before: Wuxi fanshengzi Biotechnology Co.,Ltd. Patentee before: GENETRON HEALTH (BEIJING) Co.,Ltd. Patentee before: GENETRON HEALTH(CHONGQING) LABORATORY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Nucleic acid protective solution for long-term storage and transportation of tissue samples under normal temperature conditions Effective date of registration: 20230316 Granted publication date: 20171103 Pledgee: Agricultural Bank of China Limited by Share Ltd. Wuxi Huishan branch Pledgor: Wuxi fanshengzi Biotechnology Co.,Ltd. Registration number: Y2023980035046 |